Pharmaceutical combination
    1.
    发明授权
    Pharmaceutical combination 有权
    药物组合

    公开(公告)号:US08846765B2

    公开(公告)日:2014-09-30

    申请号:US13159845

    申请日:2011-06-14

    摘要: A pharmaceutical combination comprising as components (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol compound, and (b) at least one NMDA-antagonist, a pharmaceutical formulation and a dosage form comprising such a combination, and a method of treating pain, e.g. inflammatory pain or neuropathic pain, in which components (a) and (b) are administered simultaneously or sequentially to a mammal, with component (a) being administered either before or after component (b), and with components (a) or (b) being administered to the mammal either via the same pathway of administration or via different pathways of administration.

    摘要翻译: 一种药物组合,其包含作为组分(a)至少一种3-(3-二甲基氨基-1-乙基-2-甲基 - 丙基) - 酚化合物和(b)至少一种NMDA拮抗剂,药物制剂和剂量 包括这种组合的形式,以及治疗疼痛的方法,例如 其中组分(a)和(b)同时或依次施用于哺乳动物,其中组分(a)在组分(b)之前或之后施用,和组分(a)或(b )通过相同的给药途径或通过不同的给药途径施用于哺乳动物。

    Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID
    6.
    发明申请
    Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID 审中-公开
    包含6-二甲基氨基甲基-1-(3-甲氧基 - 苯基) - 环己烷-1,3-二醇和NSAID的药物组合

    公开(公告)号:US20100063009A1

    公开(公告)日:2010-03-11

    申请号:US12554243

    申请日:2009-09-04

    摘要: A combination comprising (a) at least one 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol component, and (b) at least one non-steroidal anti-inflammatory drug (NSAID) component; a pharmaceutical composition and a dosage form comprising such as combination, and a method of treating pain and/or ostheoarthritis in a mammal characterized in that components (a) and (b) are administered simultaneously or sequentially to said mammal, in which component (a) may be administered before or after component (b), and in which components (a) or (b) are administered to the mammal either via the same or a different pathway of administration.

    摘要翻译: 包含(a)至少一种6-二甲基氨基甲基-1-(3-甲氧基 - 苯基) - 环己烷-1,3-二醇组分和(b)至少一种非甾体抗炎药(NSAID)组分 ; 药物组合物和包含诸如组合的剂型以及治疗哺乳动物疼痛和/或骨关节炎的方法,其特征在于组分(a)和(b)同时或依次给予所述哺乳动物,其中组分(a )可以在组分(b)之前或之后施用,并且其中组分(a)或(b)通过相同或不同的施用途径施用于哺乳动物。